View Older Stories View More Recent Stories

May 5, 2026 06:19AM IDEAYA Biosciences (IDYA) Misses Q1 EPS by 12c

Apr 30, 2026 06:01AM IDEAYA begins FDA application for uveal melanoma drug under fast-track program

Apr 14, 2026 07:08AM Ideaya Biosciences (IDYA) PT Raised to $54 at Guggenheim

Apr 14, 2026 06:39AM Ideaya Biosciences (IDYA) PT Raised to $53 at RBC Capital

Apr 13, 2026 03:08PM Ideaya Biosciences (IDYA) PT Raised to $52 at Mizuho, 'we recommend being opportunistic'

Apr 13, 2026 03:04PM Ideaya Biosciences (IDYA) PT Raised to $40 at Oppenheimer

Apr 13, 2026 02:05PM Ideaya Biosciences (IDYA) PT Raised to $65 at Truist Securities

Apr 13, 2026 01:29PM Ideaya Biosciences (IDYA) PT Raised to $35 at Goldman Sachs

Apr 13, 2026 10:14AM Ideaya Biosciences (IDYA) PT Raised to $58 at Wedbush

Mar 23, 2026 03:30PM IDEAYA Biosciences (IDYA) April 22.50 ad May 30 puts active

Mar 23, 2026 02:21PM RBC Capital on Ideaya Biosciences (IDYA): 'We remain positive on the upcoming data readout'

Mar 23, 2026 12:01PM Jefferies on Ideaya Biosciences (IDYA): 'simulation suggests ~90%+ chance for stat sig mPFS w/ 80% POS for mPFS >7'

Mar 23, 2026 09:42AM Mizuho on Ideaya Biosciences (IDYA): 'we recommend being opportunistic on weakness'

Mar 23, 2026 04:56AM Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens Ahead of mPFS Data

Mar 16, 2026 07:24AM Cantor Fitzgerald Reiterates Overweight Rating on Ideaya Biosciences (IDYA)

Mar 9, 2026 09:12AM Truist Securities Reiterates Buy Rating on Ideaya Biosciences (IDYA): "refined strategy in MTAP net positive"

Mar 6, 2026 06:50AM IDEAYA Biosciences (IDYA) Added to Citi Catalyst Watch List

Feb 18, 2026 09:17AM Cantor Fitzgerald Reiterates Overweight Rating on Ideaya Biosciences (IDYA)

Feb 17, 2026 07:33AM IDEAYA Biosciences (IDYA) Reports In-Line Q4 EPS

Feb 6, 2026 04:45AM Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens: Shares Can Gain

Jan 7, 2026 12:42AM UBS Assumes Ideaya Biosciences (IDYA) at Buy

Jan 6, 2026 09:41AM Ideaya Biosciences (IDYA) PT Raised to $60 at Truist Securities

Dec 12, 2025 09:16AM Citi Opens 90-Day Upside Catalyst Watch on Ideaya Biosciences (IDYA)

Dec 10, 2025 06:01AM IDEAYA Biosciences Announces IND Submission for IDE574

Dec 5, 2025 04:26PM GSK terminates collaboration agreement with IDEAYA Biosciences

Dec 1, 2025 06:00AM IDEAYA Biosciences receives FDA clearance for cancer drug trial

Nov 24, 2025 07:34AM Truist Securities Starts Ideaya Biosciences (IDYA) at Buy

Nov 4, 2025 06:26AM IDEAYA Biosciences (IDYA) Tops Q3 EPS by 133c

Oct 21, 2025 04:16AM Ideaya Biosciences (IDYA) PT Raised to $41 at RBC Capital

Oct 13, 2025 04:34AM Citizens Reiterates Market Outperform on Ideaya Biosciences (IDYA); Bullish on Darovasertib

Oct 7, 2025 07:53AM Citizens stays bullish on Ideaya ahead of ESMO update

Oct 4, 2025 04:00PM Why UBS says Q4 is eventful for SMID oncology stocks

Sep 23, 2025 08:53AM UBS Reiterates Buy Rating on Ideaya Biosciences (IDYA)

Sep 12, 2025 05:40AM Mizuho Reiterates Outperform Rating on Ideaya Biosciences (IDYA)

Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'

Sep 9, 2025 09:19AM Ideaya Biosciences (IDYA) PT Raised to $38 at RBC Capital

Sep 9, 2025 08:53AM Cantor Fitzgerald Reiterates Overweight Rating on Ideaya Biosciences (IDYA)

Sep 9, 2025 07:00AM Ideaya Biosciences (IDYA) PT Raised to $30 at Leerink Partners

Sep 9, 2025 04:04AM Citizens JMP Reiterates Market Outperform Rating on Ideaya Biosciences (IDYA)

Sep 8, 2025 04:14AM Ideaya Biosciences (IDYA) PT Raised to $45 at Citizens JMP

Sep 4, 2025 03:54AM Barclays Starts Ideaya Biosciences (IDYA) at Overweight

Sep 4, 2025 03:33AM Citizens JMP Starts Ideaya Biosciences (IDYA) at Market Outperform

Sep 3, 2025 06:57AM Ideaya Biosciences (IDYA) PT Raised to $74 at JPMorgan

Sep 3, 2025 06:00AM IDEAYA Biosciences submits IND for PRMT5 inhibitor IDE892

Sep 2, 2025 06:01AM Servier licenses IDEAYA's uveal melanoma drug for $210 million upfront

Aug 18, 2025 06:01AM IDEAYA Biosciences schedules R&D day for September 8 in New York

Aug 5, 2025 06:23AM IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c

Aug 5, 2025 06:21AM IDEAYA Biosciences (IDYA) Misses Q2 EPS by 9c

Jul 30, 2025 06:40AM Ideaya Biosciences (IDYA) PT Lowered to $43 at Mizuho

Jul 22, 2025 01:01PM IDEAYA and Hengrui to present lung cancer drug data at conference

View More Recent Stories View Older Stories